The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience

Figure 1

Kaplan-Meier progression free survival (PFS) curve; median PFS from second surgery: 6 months (95% CI 3.9–8.05).